Old Web
English
Sign In
Acemap
>
authorDetail
>
Miguel Ortiz-Flores
Miguel Ortiz-Flores
Instituto Politécnico Nacional
Chemistry
Receptor
Arginase
Internal medicine
In vivo
8
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Medicina/investigación translacional: ¿quién recibe los beneficios?
2021
Guillermo Ceballos
Miguel Ortiz-Flores
Nayelli Nájera
Show All
Source
Cite
Save
Citations (0)
PXR is a target of (-)-epicatechin in skeletal muscle.
2020
Heliyon
Miguel Ortiz-Flores
Andrés Portilla-Martínez
Francisco Cabrera-Pérez
Nayelli Nájera
Eduardo Meaney
Francisco Villarreal
Javier Perez-Duran
Guillermo Ceballos
Show All
Source
Cite
Save
Citations (2)
Definiendo términos farmacológicos basados en las interacciones ligando receptor
2020
Nayelli Nájera
Guillermo Ceballos
Cristian Gonzalez-Ruiz
Isabel Hidalgo
Miguel Ortiz-Flores
Andrés Portilla-Martínez
Show All
Source
Cite
Save
Citations (0)
The cardioprotective effects of (-)-Epicatechin are mediated through arginase activity inhibition in a murine model of ischemia/reperfusion
2018
European Journal of Pharmacology
Pilar Ortiz-Vilchis
Miguel Ortiz-Flores
Marcela Pacheco
Israel Ramírez Sánchez
Aldo Moreno-Ulloa
Lourdes Vega
Alicia Ortiz
Francisco Villarreal
Ivan Rubio-Gayosso
Nayelli Nájera
Eduardo Meaney
Guillermo Ceballos
Show All
Source
Cite
Save
Citations (12)
1